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Abstract
The expression of the secondary granule protein (SGP) genes lactoferrin (LF),
transcobalamin (TBI), human neutrophil gelatinase (HNG) and collagenase (HNC) is
coordinately regulated at the level of mRNA transcription.
previously identified a silencer element in the LF promoter

Our laboratory has
which binds CCAAT

displacement protein (CDP); when CDP is overexpressed in myeloid cells, it blocks the
expression of all SGP genes. CDP is a ubiquitous repressor known to be implicated in
the regulation of many myeloid-specific genes, and we wish to determine the means by
which it acts as a stage specific repressor of multiple genes at different stages of
differentiation. Here we describe the cloning, sequencing and partial characterization of
the 5' flanking region ot the Mouse Neutrophil Collagenase (MNC) gene.

The MNC

promoter shows a high degree of conservation over more than 200bp with the human
homolog, with a 56bp stretch sharing 81.4% nucleotide identity. Within this region, we
have identified well described control elements involved in myeloid gene regulation,
including a canonical consensus sequence for the CCAAT enhancer binding protein
alpha (C/EBPa).

Functional assays will be necessary to establish the functional

significance of these regions. CDP binding sites are highly promiscuous and can only be
characterized functionally.
characterization.

The identification of the promoter will now allow such
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I.

OVERVIEW

OF

TRANSCRIPTIONAL

REGULATION

OF

MYELOID

DIFFERENTIATION

Hematopoiesis is the process by which blood cells acquire defining phenotypes
as the consequence of coordinated, cell-specific gene expression. The proliferation and
differentiation of hematopoietic cells are orchestrated by a variety of extra and intra
cellular signals. Extracellular signals, namely growth factors, signal cellular events by
binding membrane and cytoplasmic receptors. They produce their physiologic effect by
modulating the level of expression of key transcriptional regulators and directing
downstream changes in proliferation and phenotype by regulating gene expression.
The regulation of gene expression is mediated through ds-acting regulatory
sequences and the trans-acting regulatory factors which bind to them.

The locus of

biological activity of these regulatory elements is usually at the 5' flanking region of the
transcription start site of the genes, namely the promoter.
The pathway to terminal neutrophil differentiation and maturation has not been
completely outlined.

However some of the necessary transcriptional regulators

governing that process are emerging out of recent studies.
PU.l appears to be required for myeloid differentiation. PU.l is the product of
Spi-l/Sfpil/PU.l protooncogene, a hematopoietic-specific member of the ets family
expressed principally in monocytes, macrophages and B lymphocytes, but also in
granulocytes and erythroid cells. Nearly all myeloid-specific genes contain biologically
active PU.l binding sites in their regulatory regions. In one study, mice lacking PU.l
function die 1 to 3 days before their expected birth and these PU. 1-null mice show an
absence of monocytes, T and B lymphocytes and granulocytes. Further, flow cytometry
shows diagnostic Ig and T cell receptor gene rearrangements1, as demonstrated by
surface markers. Early myeloid-specific genes are expressed in embryonal stem cells
from these mice. These cells in fact show a loss of all late markers of lymphoid and
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myeloid lineage maturation2 3. Another study of PU. 1-null mice results in viable mice
with an otherwise similar defect in myeloid cell development. For example, granulocytecolony stimulating factor (G-CSF) and granulocyte macrophage-colony stimulating
factor (GM-CSF) receptor mRNA can be detected in these cells.
receptors are not detected at the protein level.

However these

The reasons for the discordant viability

of the two models are unknown.
Also implicated in early myeloid differentiation is the family of CCA AT/
Enhancer binding proteins (C/EBP)4. Shown to be a member of a family of differentially
expressed genes, C/EBP was first isolated as a protein with a basic region/leucine
zipper structure which binds a CCAAT site. It was originally purified and cloned from
rat liver and appears to have a role in adipogenesis. C/EBPa-null mice have an
impaired glucose metabolism and die within 24 hours of birth.

Late myeloid

differentiation is also impaired in these mice as they show absence of mature
granulocytic cells, and very low expression of the G-CSF receptor5 6.
Other transcription factors important for myeloid differentiaion include MZFl7'8, c-myb9, and the retinoic acid receptors10. The evidence is growing that there are
complexes of transcription factors which are necessary for regulated expression of many
of the myeloid genes.
In order to understand leukemogenesis and normal myeloid differentiation it is
important to identify and characterize cis and trans regulators that activate important
genes in the myeloid lineage.
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II. SECONDARY GRANULE PROTEIN GENE EXPRESSION IN NEUTROPHILS.

In the process of differentiation and maturation of neutrophils, a critical and
pivotal step occurs at the transition from promyelocytes to myelocytes.

Normal

progenitor marrow cells begin to lose proliferative capacity11 as they become committed
to terminal neutrophil maturation12.

Leukemic cells from patients with AML are

arrested in maturation at or before the promyelocyte stage, suggesting the critical
importance of understanding the processes involved in regulating this commitment
step.
Sequential phases of granulocyte differentiation show the acquisition of different
types of granules.

The promyelocyte stage is marked by primary ("nonspecific")

granules which are attenuated in the later stages of both neutrophil and monocyte
maturation13. As a promyelocyte advances to the myelocyte stage it acquires secondary
("specific") granules14.

Specific granules carry four major identified proteins, namely,

transcobalamin I (TCI), lactoferrin (LF), human neutrophil collagenase (HNC), and
human neutrophil gelatinase (HNG).

The rise of secondary granules provides a unique

label of commitment to terminal neutrophil differentiation.

Thus, the expression of

genes responsible for the formation of secondary granule membranes and their contents
should constitute a convenient probe for the mechanisms governing regular neutrophil
differentiation.
HNG and HNC are believed to be responsible for the turnover of extracellular
matrix and involved in the acquisition of metastatic potential in transformed cells. Our
laboratory has previously cloned and sequenced approximately lkb of the 5'flanking
region of the human neutropil collagenase gene (See Figure 1).
been characterized functionally.

This promoter has not
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Under physiologic conditions, collagenases are enzymes that cleave peptide
bonds in the triple-helical regions of collagen.

Two sets of collagenases are known: the

tissue collagenases and the collagenases implicated in gas gangrene.
The bacterium Clostridium histolyticum

that causes gas gangrene secretes a

battery of collagenases that contribute to their invasiveness by destroying the
connective-tissue barriers of the host.
Neutrophil collagenase is a tissue collagenase and is thought to play a role in
degrading collagen in inflammation.

The action of the collagenases is potentially

harmful to the host but activated collagenases can be inhibited by a family of specific
tissue inhibitors produced by most mesenchymal cells. Neutrophil collagenase probably
plays a critical role in the host response to infection as well as in conferring metastatic
potential in malignancy.

A.)Secondary granule protein gene transcription is coordinately regulated at the level
ofmRNA transcription.

Studies in several systems have shown

that secondary granule protein gene

(SGP) expression is coordinately regulated at the level of mRNA transcription.
Upon induction with G-CSF the 32Dcl3 cell line (32D) undergo differentiation to
mature neutrophils. The 32D cell line is a murine stem cell line that requires IL3. The
Berliner laboratory proved that upon induction of neutrophil differentiation with GCSF, the expression of a mouse neutrophil gelatinase gene showed a similar pattern to
that of the LF gene. Nuclear run-on assays established that regulation of expression was
transcriptional15.

Our laboratory later isolated a cDNA clone for the mouse homolog of

neutrophil collagenase, and showed comparable results in 32D cells16.
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gaattcgatgcccctccacaaatgaaacatgtgacttaaacaggtcatctaaatgtctctggaggtgatttcatctgtaa
aatggagatagtaatagcatctccctcccaaggctatgtgaagatggattggggtaatatgtggaacacagtacaaa
tgtctgggcaatcataattttttagcaaatgttcattattatcatcatcagtattgttctctttatcttttccatggaaagtc
taacttatagactagggattttctaatatgttgataccaaaccacatcctccagaagcagctctaggccccatacaaag
cctgctttgtaataacacagtcactcattctctccacatacaatgagggaggataagtacagagattctctagttgggct
ccttggtcccaagatatctaccacaaacctcaaaatattcccctgcataagttaattcaacctcaacatcttacatagtca
aaaaatgtgatccacataacttcaggattagtcccttgttccttttcctcaaccaattttgtaaaaggaaataactaaaa
catccaaaagcaaagagtagaaagttggagttttgaaaga ctgttgaaagactccatttgggggtactaaatcacatt
ataaaattgcaaaactgtcagagtgtaattaacctatgttgcttcatattcctgatgcagcaattgtttaagacatggct

ttaaagagggactgcaagagagctgtgagtgaCACATGATGCTGTGAACCTCAGGGTGCTCGC
CAGGGAAGGGCCCNNGGCGTCACCTTGCAACTCCCAAGAACGGACCTAT
GGAGAAAGAAAGCCAGGAGGGGTCATGAGTTTGAAGAGAAGATCATGT
TCTGCCTGAAGACGCTTCCATTTCTGCTCTTACTCCATGTGCAGATTTCCA
AGGCCTTTCCTGTATCTTCTAAAGAGAAAAAATACAAAAATTGTTCAGGT
AAATGAACTATCAGTTAGGTGATGTTTGATTTGCTGATTATTAGGAAATA
GTGTGGGTTGTTTTCTCTTGTTAATTAAAACAGCCTGAAAGAAATTATTTG
GGTGATTAGTTTGAGATTGAACATCTCCTTTTAGTGATTTGGAGGGTTCCA
AGCTGGTAAGGACTAGGCCTTTTAAAAGACGGACATGAAAACAAGCTGC
ATTC
Figure. 1 - DNA sequence of the 5' Flanking region of HNC gene. Capitalized
sequence corresponds to transcribed region as intimated by cDNA data.
Region of conservation with the mouse homolog is italicized, with highest
conservation in bold faces. Translation start site is underlined.

6

MPRO cells are derived from murine bone marrow stem cells which have been
retrovirally transduced with a dominant negative retinoic acid receptor (RARa) by Tsai
et al. who described two cell lines from such transductions: a stem cell factor-dependent
cell line, EML, which fails to differentiate into early myeloid precursors until treated
with all trans retinoic acid (ATRA), and a GM-CSF dependent line, MPRO, which is
blocked in differentiation at the promyelocyte stage.

Our laboratory has induced

neutrophil differentiation in both EML and MPRO with appropriate growth factors in
the presence of ATRA, and has shown phenotypic maturation to mature neutrophils
associated with rapid increase in LF gene expression .
In further studies, the laboratory examined the sequential expression of the
primary and secondary granule protein genes in purified bone marrow progenitors
induced with cytokines to undergo in vitro differentiation to terminal neutrophils. Over
a period of 10-12 days, the cells progressively matured to the late metamyelocyte and
band stage. Induction with G-CSF resulted in a stage-specific expression of primary and
secondary granule proteins, with asynchronous expression of nonspecific granule
proteins starting from days 1-5, and concommitant expression of lactoferrin and
transcobalamin I (SGPs) from day 7-817.

B.)SGPgene expression is coordinately blocked in abnormal myeloid differentiation

Leukemic cell lines proliferate independently from growth factors. The HL60
and NB4 cell lines were derived from patients with acute promyelocytic leukemia and
are used in the study of neutrophil differentiation. Our laboratory has shown an
irreversible block to SGP gene expression in inducible leukemic cells
HL60

cells are inducible to phenotypic maturation with

12-0-

tetradecanoylphorbol-13-acetate (TPA) to monocytes and with dimethyl sulfoxide
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(DMSO) to granulocytes. HL60 cells induced with DMSO undergo defective neutrophil
maturation,

manifested by a coordinate loss of secondary granule protein gene

expression. In previous studies our laboratory has characterized the defect in secondary
granule protein gene expression in uninduced and DMSO-induced HL60 cells. Nuclear
run-on assays confirmed that the secondary granule protein mRNA are not transcribed.
In addition, our laboratory has sequenced more than 600bp of the HL60 lactoferrin
promoter region and shown that it is not defective structurally. Since the SGP genes are
not linked these results suggest that the failure of gene expression in these cells reflects a
regulatory defect in part via a trans-acting factor18.
Similar findings have been shown in the NB4 cell line which exhibits a defect in
granulocytic maturation in ATRA-induced cells.

They lack expression

of

all the

secondary granule protein genes upon induction with ATRA19.
Further, specific granule deficiency (SGD), is a congenital disorder characterized
by recurrent infections, the absence of neutrophil secondary granules, and marked
deficiency or absence of their content proteins.

We demonstrated insignificant mRNA

levels for all of the secondary granule protein genes as well as for defensins from bone
marrow cells obtained from a patient with SGD. These levels were comparable to the
previous SGP levels measured in this patient's neutrophils. This is consistent with the
notion that a common frans-acting factor governing secondary granule protein gene
expression may be compromised in SGD20,21'.
Finally, studies of patients with newly-diagnosed acute leukemia have shown
absence and/or abnormalities in secondary granule protein gene expression in
apparently normal neutrophils which are actually part of the malignant clone.

In light of these studies our laboratory hypothesizes that one irregularity of the leukemic
cell is a compromise of the differentiation program via common cis and trans acting factors
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which interrupts later events in neutrophil maturation, as reflected in the coordinate loss of
expression of secondary granule proteins.

9

III. IDENTIFICATION OF A SHARED REGULATORY PATHWAY FOR MULTIPLE
MYELOID-SPECIFIC GENES.

A) Identification of a silencer within the LF promoter

The LF promoter has been extensively studied in our laboratory. LF promoter
sequences spanning -384, -649, -726,-750, -800, and -916 bp upstream of the LF
transcription start site were subcloned into the pGL2 promoterless vector. These
constructs were assayed by transient transfection into many leukemic hematopoietic
cell lines including K562, a cell line isolated from a patient with CML in blast crisis, and
HEL, a human erythroleukemia cell line; these leukemic lines do not express LF. These
plasmids were also assayed in the uninduced 32Dcl3, the IL-3 dependent murine
myeloid progenitor cell line mentioned earlier, which expresses the LF gene only after
G-CSF-induced differentiation. Measurable luciferase activity was detected for the -384,
-649, -726,-750 and -800bp constructs. These results were duplicated in HeLa cells, a
non-hematopoietic cell line. However, the -916bp construct only expressed background
levels of activity suggesting the presence of a silencer between the 800bp and 916bp
upstream of the LF gene transcription start site40.
Our laboratory has subsequently shown that the silencing effect is mediated by a
nucleotide sequence containing a triad of octamers reported below:
5' ATGTATTTACGAGATGTATTCTAGAAGCAGTATTCTAGCTTTTGAATTTT 3’
Deletion plasmids where a 56bp sequence containing the triad of octamers was
removed expressed levels of luciferase activity comparable to the -726bp suggesting that
the 56bp deleted fragment is a cis-acting silencer of LF expression.

B) Identification of CDF as binding protein for silencer element:
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Our laboratory has studied the identified silencer element for DNA-protein
interactions by mobility shift assays and UV crosslinking.

Data from these studies

confirm the presence of a large protein-DNA complex (180kD protein) in LF non¬
expressing cells40 which is absent from LF expressing cells. This has been shown to be
bound by CCA AT displacement protein (CDP/cut) described more extensively below.
To further establish the role of CDP in LF gene expression Khanna-Gupta et al.
isolated 32D cells stably transfected with a CDP expression vector. Tissue cultures of
transfected cells, and single cell clones overexpressing CDP show a complete loss of LF
mRNA upon induction with G-CSF, while these cells maintain the ability to undergo
morphologic differentiation.

Remarkably, CDP overexpression also prevents the

expression of neutrophil gelatinase, neutrophil collagenase, and of the myeloid specific
gene gp91 phox (Figure 2)39'40.
The

coordinate loss of secondary granule protein gene expression upon

overexpression of CDP intimates that the coordinate loss of SGP expression in leukemia
and SGD could reflect an irregularity of modulation of CDP binding and/or CDP
expression. In light of the fact that CDP has been shown to interact with a variety of
myeloid specific genes, including PU.l, our laboratory postulates that modifications in
CDP binding may be crucial to stage-specific gene expression throughout the process of
myeloid differentiation.
An understanding of how CDP interacts with different genes at different phases
of the maturation program may therefore provide critical insights into the process of
normal differentiation as well as the dysregulation in acute leukemia.

Y
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Figure 2.- Northern Blot showing suppression of SGP gene expression in 32D cells
(Courtesy of Nathan Lawson. See reference 38.
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IV. CDP AND POSITIVE REGULATORS IN MYELOID PROMOTERS.

Tissue-specific control of gene expression appears to be partly mediated by
negative regulatory elements as exemplified in the growth hormone22, MHC23,and
lysozyme24 gene systems. These systems uniformly exhibit tightly regulated expression
that is tissue and stage specific, as with the repression of the lysozyme gene in the stages
prior to myeloid differentiation25, and the suppression of

immunoglobulin gene

expression in immature pre-B cells26.
Originally described as a repressor of the sea urchin testis-specific H2B gene
promoter27, CDP is constitutively expressed in most cells. CDP is a member of a
homeodomain family involved in lineage specification.

This family incudes the

Drosophila cut protein and CDP is related to the canine clox18 (Cut like homeobox) and
murine cwx-129'30'31. CDP/cut proteins contain four possible DNA-binding motifs with
overlapping but distinct sequence specificities32, but often binds specifically to disparate
sequences.
The role of CDP has been demonstrated in the repression of a wide variety of
genes including the human myeloid-specific cytochrome b558 heavy chain gene, gp91
phox, the human c-myc gene33, human y-globin gene, mouse NCAM gene, and mouse
myosin heavy-chain gene.

Recent studies of the interaction of CDP with the histone

gene locus would lead one to infer that it is a part of a complex with Rb, and may have a
critical role in modulating cell cycle events34.
The control of gene expression is usually dependent on a complex interplay of
positive and negative regulatory factors.

For example, although constitutively

expressed in myeloid cells, CDP shows decreased binding for preferential binding of
CCAAT enhancer protein, and

resultant gp91-phox expression in maturing

neutrophils35'36. There is growing evidence that such a complex interaction is central to
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the regulation of myeloid specific genes, especially of the myeloid cytokine receptors.
As mentioned earlier binding of PU.l appear to be required for myeloid gene
activation4,5.

Another group of positive regulators, namely the C/EBP factors also

appear to be major modulators of myeloid gene expression with binding sites often
proximal to PU.l binding elements.

All C/EBP genes are activated in myeloid

differentiation with relative abundance of the different proteins. In addition to PU.l and
C/EBP, the AML1 transcription factor seems necessary for optimal myeloid promoter
function.

Mutation of AML1 binding site has been shown to dramatically decrease

myeloid promoter function4537.
Tissue-specific gene expression is likely to be highly complex and tightly
orchestrated by the positive and negative arms of regulation. We hypothesize that CDP
plays an integral role in this complex interaction.
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V. STATEMENT OF PURPOSE

With the aim of further characterizing the spectrum of CDP-regulated genes and
the means by which it acts as a stage specific repressor of multiple genes we have
endeavored to identify and sequence the mouse neutrophil collagenase promoter and
compare it to the LF and HNC promoters.
We propose that one of the ways CDP may mediate its effects is through common
cis-acting elements in the promoters of its target genes.
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VI. MATERIALS AND METHOD

A. Cell lines and Cloning of the full length MNC cDNA. (done by Nathan Lawson)

The EML line, a murine stem cell line, is stem cell factor (SCF)-dependent,
multipotential, and displays a specific block to differentiation along the myeloid lineage
with SCF and IL3. When induced with IL3 and SCF in the presence of high doses of alltrans retinoic acid (ATRA), EML cells differentiate to promyelocytes. Transfer to GMCSF in the presence of ATRA will promote full differentiation to neutrophils.

MPRO

cells were selected for growth in GM-CSF, and are blocked in differentiation at the
promyelocyte stage.

When induced with ATRA, they too will mature to neutrophils.

Induction of EML with IL3, SCF, and ATRA for three days, followed by culture in GMCSF in the absence of ATRA results in a cell line blocked at the promyelocyte stage. This
line, termed EPRO, is similar in phenotype to the MPRO cell line.

Using cDNA

representational difference analysis to compare the EPRO cell line to the multipotent
stem cell line from which it was derived, EML, our laboratory had previously isolated a
full length 1.9 kb MNC cDNA. That fragment was subsequently cloned in pBluescript
(Stratagene, LaJolla,CA) vector.

B. Generation of a probe for screening a genomic library.

The above construct was used to transform DH 10B electromax cells according to
standard protocol. The transformed cells were lysed by alkali and the amplified clone
was isolated by ultracentrifugation, CsCl/EtBr gradients according to standard
protocol.. The product was digested with appropriate restriction enzymes and purified
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on an agarose gel. The 1.9 kb MNC cDNA was radiolabelled by nick translation and
used as a probe to screen the 129 SV mouse genomic library which was kindly provided
by Dr. Archibald Perkins.

C. Titering of library.

Phage were diluted in SM (NaCl 5.8g/L;MgS04/7H20 2.0 g/L; 1M Tris,pH 7.5
50ml/L;2% Gelatin 5ml/L) to estimated concentrations of 103,104, and 105/ml and plated
on small NZY agar plates with l-2gl/plate.

100 |il of overnight host bacteria, LE 392,

were adsorbed to phage at 37°C for 15 minutes, diluted in 3ml of molten agarose and
poured onto warmed plates which were subsequently incubated at 37°C overnight.
Plaques were subsequently counted to determine phage titer.

D. Screening of 129SVgenomic library.

Phages were plated at 10b plaque forming units (pfu)/plate and 30 plates were
used to screen approximately 1.5xl06 recombinants.

Host bacteria were adsorbed to

phages at 300|il/plate at 37°C for 30 minutes prior to overnight incubation. Duplicate
BioTraceNT nitrocellulose membranes (Gelman Sciences, Ann Arbor, MI) were lifted
and hybridized at 65°C overnight to the nick-translated MNC cDNA probes in
hybridization solution (4xSSC;5x Denhardt's;.l% SDS; salmon sperm DNA; 0.1% Na
pyrophosphate) and washed with 2xSSC(300mmol/L NaCl,60 mmol/L NaCitrate)/0.5%
SDS twice at room temperature for 5 minutes followed by 15 min. of washing in
2xSSC/0.1% SDS at room temperature and finally one high stringency wash in
0.5xSSC/0.1% SDS at 65°C for 30 min..

Films were exposed for 48 hrs. for visualization

of positive plaques. Positive plaques were purified by secondary and tertiary screenings
using the above method.
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E. Phage amplification.

The tertiary core phage was titered as described above and the phage were
plated on NZY agarose plates at lxlO5 pfu/plate and grown overnight at 37°C for
confluent lysis. The small plates were then overlayed with 9ml of SM and gently shaken
at room temperature overnight.

The SM was then collected spun and the supernatant

stored. Tertiary phages were thus amplified to 109 pfu/plate.

The phagemids were

subsequently excised according to standard protocol and digested by several restriction
enzymes. Genomic fragments were subcloned into the pbluescript plasmid vector.

F. Generation of probes for isolation of 5' region of the MNC gene..

The 1.9 kb MNC cDNA was digested with appropriate enzymes to generate a
500bp probe for the 5' portion of the MNC cDNA.

That fragment was subsequently

radiolabelled by Nick translation as described above. That probe was used for initial
screening of genomic clones and preliminary sequences obtained were used to generate
upstream genomic oligonucleotides. These 3:P

labeled 22-24bp single stranded

oligonucleotides, including one corresponding to the 5' end of the MNC cDNA were
used for further screening of genomic clones.

G. Isolation of the 5' flanking region of the MNC gene.

The genomic constructs were used to transform DH 10B electromax cells by
electroporation.

Transformed cells were plated and incubated overnight at 37°C.

Nitrocellulose filters (Gelman Sciences, Ann Arbor,MI) were lifted and hybridized at
37°C overnight to the probes described above. Positive colonies

were grown and lysed
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according to Qiagen Maxi protocols and plasmids were isolated and submitted to the
Yale sequencing facility for sequencing by the dideoxy chain termination method.

H. Analysis of sequences.

Sequences were analyzed using the databank of the NIH and DNA star.

19

VII. RESULTS.

A. Isolation of the MNC gene.

Using the 129 SV genomic library, approximately 1.5xl06 phages were screened
with the 1.9kb MNC cDNA resulting in 17 positive clones. From these 5 clones were
purified by secondary and tertiary screens.

B. Isolation of the 5' flanking region of the MNC gene.

Two of the 5 positive clones were digested and subcloned in pBluescript and
screened with the 500bp MNC cDNA corresponding to the 5' region and sequenced.
These sequences were used to design single stranded oligonucleotides, including one
corresponding to the 5' end of the MNC cDNA, with which to obtain further upstream
sequences.
5 subclones were isolated, representing three independent DNA fragments. Two
of these clones were identical, 5kb in size , and contained the first exon of the MNC gene
and 4kb of the 5' flanking region. Two other identical clones (1.8kb) contained most of
the first intron and part of the second exon. We have subsequently established the first
intron to be l,839bp in length. The last positive clone was found to be a subclone of the
latter two clones (Figures 3 & 4).
Previous studies of the MNC cDNA have established the translation start site
and suggested a relatively short 5' untranslated (UTR) region of 73 nucleotides. It
remains to be determined by SI nuclease and primer extension if there is additional 5'
untranslated sequences although this is unlikely since the HNC 5' UTR is approximately
95 n.t.

20

The clone containing the 5' flanking region was digested with several resriction
enzymes and a map of that region was generated (Figures 6,7 & 8).

4
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Figure 3.- Pst digests of two positive subciones. The subclones are identical in size
approximately 5kb in size.
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Figure 4 - EcoRI/HindlH digests of three positive subclones. Two are identical in size and contain the
genomic subfragment with the first intron of the MNC gene.
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C. Sequence analysis of the 5'flanking region of the MNC gene.

Sequence of 1314bp 5' of the putative transcription start site as well as 1839bp of
the first intron was obtained(Figure 5)

Analysis of the sequence at the 5' end of the

MNC gene shows several well-described control sequences.

A

CCAAT element is

found at -6 as well as an AP.l recognition site at that position. There is a c-myb binding
element at -111, a CACCC motif at -200 and a PU.l binding site at -253.

A C/EBPa

binding site is found in the reverse direction at -530 and further upstream a C/EBP(3
element is found at -772 . Multiple binding sites for the zinc-finger transcription factor
GATA-1 are at -796, -1038, and -1169 as well as a TGGCA element at -1000. Finally we
found at -1269 and at -1221 consensus sequences to the c-ets-2 and c-ets-1 binding
factors.
The sequence between -125 and -69 shows a high degree of sequence
conservation with the human homolog of neutrophil collagenase.

That region shares a

81.4% similarity index with a region in the 5' flanking region of the human neutrophil
collagenase (Figure 9).

In the human counterpart that region contains a canonical

consensus binding site for C/EBPa whereas the sequence in the mouse genome is
imperfect. Further the region spanning 254bp upstream of the 5' untranslated region
maintains a high degree of conservation, sharing a 71.1% simlarity index with the
corresponding region in the promoter of the human neutrophil collagenase. The role of
this region in regulating MNC expression is not yet established but the high
conservation in regions that do not encode protein suggests that it may be important.
No comparative octamer repeats, namely a negative regulatory element, to the
LF promoter were found in our preliminary analysis and sequence. This is probably not
relevant since CDP binding is promiscuous and can only be defined functionally.
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c-ets-2

PU.l

agttcattttagggctgagantaaaaacttagtctgtgaactacttcctttcaggattgaggaacaggagttagattcgtgaagacaggcaggcaggaagaga
GATA-1

Ap.2

gcccagtgccntgtgtcaccacatcatctggaagcccttcactcaccctcctagcactctggggatgtctgagacatctatctccttctctcccttgtccttttgtccct
TGCCA motif

GATA-1/Octamer motif

ggatgtaggccaaagttttccacttgctgtgagcccacagttactgatggtccagcctggattcaaatagcaggttgatgaactagagcctggtataggatggg

ctctgtttctctcaccatactcatgggcttgagtcctatgcaaagtgagcatgtgcctttcctagtcttccagcctctgcctctcctgcaaaattatagcaatagtgtgt
GATA-1
tgctctgaaagctgtatgagaatagggcatttagttgtcattaacatgtttgaaacattgtaagtacaacagatgttagttttcgtcttaactatcactatctttgtcct
C/EBPp
ttctctggaaaaacccaccttatagtgaatgttttagtacatctatagcagtcatgccacacagaagctgctgtttacgtatgtatatggacgtgtgcatttatttaa

aagtgaatgttcatgttttgtgtgtgctgtaagtgggatttgtttgtttgttttgtgacagggtctctaactagcctggaacttaccaagtagactaggttgactggc
C/EBPa (reversed)
caataagctgcaaacaccccctgcctggcacagaccaggaccgagattatactcatgtaccactaagttcagttttttacctgcatgctgagaatcaaattcagg
AP-2
ccctcatgcttgtgtgacaagtactttcctaacaaagccatcatctctagatgctgcttttggtccccacacaaagcctgctttggcacacgctatcaggcagcagt

Pill
ggtggcttagaaacagaagtcttacaggtgtgccaccgcttcccaagatgatcgctgaacattcttaaaatattgccccgattaactagcacaacttcctcattac
caccc
acacagacagaaactggaagactgtagcccccgtgccagccacctcaccctgacagtttacaaaagtagcgatccatcctcttgctctfgffgflflfgflcfcccco?
c-myb;C/EBPa (in human homolog)
cttctaggtccaaatcacattctaacattgaagaactgtcagagtgcggttagctatgttgcctcatactgcttaggcagaagttgctcaagatgtagctttataag
CCAAT

Sp.l

ggaccagacaagagcagtgattggcagGGGATGCTGTGAGCTTGAGGGCACTTGCCAGAGGGGCAGAGGAAGGC

Figure 5.- Sequence of 5' Flanking region of MNC gene.

Well described

control elements are illustrated. Exon is in capitals. Region of high
conservation is italicized with highest conservation in bold faces.
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Figure 6.- Restriction map of 5' flanking region of MNC gene.
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Figure 7 - Restriction digests of plasmid construct containing the 5kb insert. The
cloning site is Pst and our molecular weight standard was Lambda DNA cut with
Hindlll and PhiX174 with Haeill.
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Figure 8.- Restriction digests of plasmid construct containing the 5kb insert. The cloning
site is Pst and our molecular weight standard was Lambda DNA digested with Hindi 11
and PhiX174 cut with Haelll.
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c-myb; C/EBPc/. binding element
5'

_

Humn

3'

AAATCAGA3TTATAAAATKX!AAAACIUK^
IIIIIIIIII III IIII I IIIIIIIIIIIII

II

IIIIIIIII IIIII

AAATCACAITCTAACATTGAAGAACTGT^
5'

Mouse

3'

Figure 9.- Region of 81.4% identity in human and mouse
neutrophil collagenase promoters.

This region is

italicized and in bold faces in the complete sequences
reported in previous figures.
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VIII. DISCUSSION

We report here the cloning of the 5' flanking region of the MNC gene, the first
exon and the first intron (data not shown) as well as mapping studies of 4kb of the
promoter of the MNC gene. We further report preliminary characterization of cis-acting
5' promoter sequences.
Our studies have been aimed at understanding the role of CDP in regulating
the MNC gene within the context of the neutrophil secondary granule proteins. It has
already been shown that CDP overexpression blocks the expression of all SGP genes
including the MNC gene38.

It is postulated that a disruption in early myeloid

differentiation mediates continued binding of CDP and thereby blocks SGP gene
expression in abnormal myeloid differentiation.
The silencer element identified in the LF promoter is highly conserved
between the mouse and human LF.

The overall homology at the nucleotide level

between the human and mouse LF promoters in this region is 82.5% with conservation
of the octamer repeats suggesting a high functional importance in regulating gene
expression39 Our preliminary results suggest that CDP recognizes a different sequence in
the MNC promoter, pending further upstream sequencing. This is not surprising since
CDP lacks a well defined consensus binding sequence. Studies by Liu and Skalnik35,36'40
have shown differential affinity for the different DNA binding domains of CDP for
different sites within the gp91 phox promoter. Furthermore, association of recombinant
proteins through their GST portions increased binding affinity, suggesting that DNA
binding activity is enhanced by potential interactions of different binding domains
binding to different regions of the promoter40.
promoter should be sought.

A putative silencer within the MNC
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The role of the cis—acting sequence elements in the regulation of MNC remains
to be established with physiologic studies. However several are of potential interest.
The transcription start site has not yet been mapped but perhaps the most
important cis regulating elements lie within the 254 bp upstream of the untranslated
region which share a high degree of conservation with the HNC promoter.

As

mentioned earlier that region corresponds to a C/EBPa canonical consensus sequence in
the HNC promoter.

Many studies suggest that in the hematopoietic system, C/EBP

factors may be specifically expressed in myeloid cells, as indicated earlier. C/EBPa,
C/EBP(3 and C/EBP5 have been detected in all myeloid cell lines. C/EBPa has been
identified as the major form of these proteins that binds to the promoters of the M-CSF
receptor and GM-CSF receptor at the a sites and trans-activate them in myeloid cell
lines4,5.
It has been shown that C/EBP(3 regulates the ILlj3 promoter consistent with the
role of this member of the family in activation by cytokines like IL6 and LPS. Targeted
disruption of C/EBP[3 leads to defects in killing of bacteria and tumor cells by
macrophages4,5. It is not surprising to find a binding site for this transcription factor as
one would expect an increase in MNC synthesis as part of the broader expansion of the
granulocyte mass in the inflammatory response.
The transcription

factor PU.l has been previously indicated to be crucial for

terminal myeloid gene expression and differentiation4 5. Most of the myeloid promoters
lack a TATA box. They are often dependent on an SP.l site which confers specificity,
activity and inducibility.

Many of these promoters, including the MNC 5' flanking

region, have a PU.l binding site upstream of the transcription start site. It is thought
that PU.l activates these promoters by recruiting TATA binding

protein4 \

Functionality of the site remains to be shown.
Of note , many GATA-1 canonical consensus sequences as well as a c-myb
binding site are reported, c-myb is involved in early hematopoiesis whereas GATA-1

1
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has a predominant role in erythropoiesis. Interestingly we did not identify an MZF-1
element.
In summary, we have isolated two genomic clones which together include
4kb of the 5' flanking region of the MNC gene, the first exon and part of the second
exon. The 5' flanking DNA contains several potential cis-acting regulatory elements
whose physiologic role remains to be more fully defined. We have found the region
immediately upstream of the translated sequence highly conserved between the human
and mouse homologs over more than 200bp.

Confirmation of the role of these

sequences in mediating MNC expression, as well as identification of potential CDP
binding sites, awaits functional analysis of the promoter.

ACKNOWLEDGEMENTS

This work has been funded by the Howard Hughes Medical Institute to which I am
forever grateful. I wish to express my appreciation and thanks to Theresa Zibello who
has been supportive in so many ways, Nathan Lawson for his technical expertise and
Nancy Berliner for her guidance and inspiration. A.K. Gupta andN. Maun I couldn't
have done it without you.

REFERENCES

^cott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in
the development of multiple hematopoietic lineages. Science 265: 1573-1577,
1994.
"Olson MC, Scott EW, Hack AA, Su GH, Tenen DG, Singe H, Simon MC. PU.1 is not
essential for early myeloid gene expression but is required for terminal myeloid
differentiation. Immunity 3: 703-714, 1995.

32

Sorbet BE, Anderson KL< Conners K, Smith KA, Henkel G, Sinh CD, McKurcher SC, Maki
RA. The disruption of the PU.1 gene results in the loss of GM-CSF and G-CSF
receptors. Blood 88: 629a, 1996.
4Zhang DE, Hohaus S, Voso MT, Chen H-M, Smith LT, Hetherington CJ, and Tenen DG.
Function of PU.1, C/EBP, and AML1 in early myeloipoiesis: Regulation of mutliple
myeloid CFS receptor promoters. Current Topics in Microbiology and Immunology,
L Wolff and AS Perkins, eds. Springer-Verlag, Berlin, p. 137, 1996.
5Zhang P, Zhang D-E, Wang N, Hetherington CJ, Darlington GJ, and Tenen DG. Absence of
G-CSF signaling and neutrophil development in C/EBPa deficient mice. Blood 88:
630a, 1996.
7Hromas R, Collins SJ, Hickstein D, et al. A retinoic acid-responsive human zinc finger
gene, MAF1, preferentially expressed in myeloid cells. J Biol Chem 266: 1418314187, 1991.
8Bavisotto L, Kaushansky K, Lin N, Hromas R. Antisense oligonucleotides from the
stage-specfic myeloid zinc finger gene MZF-a inhibit granulopoiesis in vitro. J Exp
Med 174: 1097-101, 1991.
9Mucenski ML, McCLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga
DW, Scott WJ, Potter SS. A functional c-myb gene is required for normal murine
fetal hepatic hematopoiesis. Cell 65: 677, 1991.
10Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Cancer
Res 43: 3034-3040, 1083.
"Janoshowitz H, Moore MAS, Metcalf D. Density gradient segregation of bone marrow
cells with the capacity to form granulocytic and macrophage colonies in vitro. Exp
Cell Res 68: 220, 1971.
12Warner HR, Athens JW. Analysis of granulocyte kinetics in blood and bone marrow.
Ann NY Acad Sci 113: 523, 1964.
13Bainton DF. Neutrophil granules. Br. J Hematol 29: 19, 1975.
14Bainton DF, Ullyot JL, Farquhar MG. The development of the neutrophil secondary
granule. J Exp Med 134: 907, 1971.
15Graubert T, Johnston J, Berliner N. Cloning and expression of the cDNA encoding
mouse neutrophil gelatinase: Demonstration of coordinate secondary granule protein
gene expression during terminal neutrophil maturation. Blood 82: 3192, 1993.
16Lawson N, Khanna-Gupta A, Berliner N. (1998). Isolation and Characterization of the
cDNA for mouse neutrophil collagenase. Demonstration of shared negative
regulatory pathways for neutrophil secondary granule protein gene expression.
Blood 91 (7), (April 1, 1998)

I

33

17Berliner N, Hsing A, Sigurdsson F, Zain M, Graubert T, Bruno E, Hoffman R. G-CSF
induction of normal human bone marrow progenitors results in neutrophil-specific
gene expression. Blood, 85:799, 1995.
18Johnston J, Rintels P, Chung J, Sather J, Benz EJ, Berliner N. The lactoferrin gene
promoter: Structural integrity and non-expression in HL60 cells. Blood 79:
2998,1992.
19Khanna-Gupta A, Kolibaba K, Berliner N. NB4 cells exhibit bilineage potential and an
aberrant pattern of neutrophil secondary granule protein gene expression. Blood
84: 294, 1994.
^Johnston J, Boxer LA, Berliner N. Correlation of RNA levels with protein deficiencies
in specific granule deficiency. Blood 80: 2088, 1992.
21Lomax KJ, Gallin Jl, Benz EJ, Rado TA, Boxer LA, Malech HL. Selective defect in
myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency.
J Clin Invest 83: 514, 1989.
^McCormick A, Wu D, Castrillo J-L, Dana S, Strobl J, Thompson EB, Karin M.
Extinction of growth hormone expression in somatic cell hybrids inovlves
repression of the specific trans-activator GHF-1. Cell 55: 379, 1988.
23Miyazaki J, Appella E, Ozato K. Negative regulation of the major histocompatibility
class I gene in undifferentiated embryonal carcinoma cells. Proc Natl Acad Sci USA
83: 9537, 1986.
24Blau H. Differnetiation requires continuous active control. Ann Rev Biochem 61:
1213, 1992.
25Baniahmad A, Muller M, Steiner C, Renkawitz R. Activity of two different silencer
elements of the chicken lysozyme gene can be compensated by enhancer elements.
EMBO J. 6: 2297, 1987.
26Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1,
delta) that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin
heavy chain mu E^ site. Proc Natl Acad Sci USA 88: 9804, 1991.
27Barberis A, Superti-Furga G, Busslinger M. Mutually exclusive interaction of the
CCAAT_binding factor and of displacement protein with overlapping sequences of a
histone gene. Cell 50: 347-359, 1987.
^Andres V, Nadal-Ginard B, Mahdavi V. Clox, a mammalian homeobox gee related to
Drosophila cut encodes DNA-binding regulatory proteins differentially expressed
during development. Development 116: 324-334, 1992.
^alarche I, Tissier-Seta JP, Hirsch MR, Martinez S, Gordis C, Brunet J-F. The mouse
homeodomain protein Phox-2 regulates NCAM promoter activity in concert with
Cux/CDP/cut and is a putative determinant of neurotransmitter phenotype.
Development 119: 881-896, 1993.

'

34

^Andres V, Nadal-Ginard B, Mahdavi V. Clox, a mammalian homeobox gee related to
Drosophila cut encodes DNA-binding regulatory proteins differentially expressed
during development. Development 116: 324-334, 1992.
31Blochinger K, Bodmer R, Jack J, Lan LY, Jan YN. Primary structure and expression of
a product from cut, a locus involved in specifying sensory organ identity in
Drosophila. Nature (London) 333: 629-635, 1988.
^Aufiero B, Neufeld EJ, Orkin SH. Sequence specific DNA binding of individual cut
repeats of the human CCAAT displacement/cut homeodomain protein. Proc Natl Acad
Sci USA 91: 7757-7761, 1994.
^Cowell IG. Repression versus activation in control of gene expression. Trend Biochem
Sci 19: 38-42, 1994.
^an Wijnen AJ, van Gurp MF, de Ridder MC, Tufarelli C, Lat TJ, Birnbaum M, Vaughan
PS, Giordano A, Krek W, Neufeld EJ, Stein JL, Stein GS. CDP/cut is the DNAbinding subunit of histone gene transcription factor HiNF-D: A mechanism for gene
regulation at the G1/S phase cell cycle transition point independent of transcription
factor E2F. Proc Natl Acad Sci USA 93: 11516-11521, 1996.
^Skalnik DG, Strauss EC, Orkin SH. CCAAT displacement protein as a repressor of the
myelomonocytic-specific gp91-phox gene promoter. J Biol Chem 266: 16736,
1991.
^Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH. Human CCAAT displacement protein is
homologous to the Drosophila homeoprotein, cut. Nature Genetics 1: 50, 1992.
37Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T. Regulation of the
myeloperoxidase enhancer binding proteins Pul, C-EBPa, (3
, and y during granulocytelineage specification. Proc Natl Acad Sci USA 93: 10838-10843, 1996.

38 Lawson N., Khanna-Gupta A., and Berliner N. Isolation and characterization of the
cDNA for the mouse neutrophil collagenase. Demonstration of shared negative regulatory
pathways for neutrophil secondary granule protein gene expression. Blood 91 (7),
(April 1 1998)
39 Khanna-Gupta A., Zibello T., Kolia S., Neufeld E., and Berliner N.. CCAAT
Displacement Protein (CDP/cut) recognizes a silencer element within the lactoferrin
gene promoter. Blood 90 (7):2784-2795,1997
^Catt DM, Luo W, Skalnik DG. Study of the novel DNA-binding domains of CCAAT
displacement protein, a repressor of the gp91-phox promoter. Blood 88: 47a,
1996.

'

-

■>

\

HARVEY CUSHING / JOHN HAY WHITNEY
MEDICAL LIBRARY
MANUSCRIPT THESES

Unpublished theses submitted for the Master's and Doctor's degrees and
deposited in the Medical Library are to be used only with due regard to the
rights of the authors.
Bibliographical references may be noted, but passages
must not be copied without permission of the authors, and without proper credi
being given in subsequent written or published work.

This thesis by
has been
used by the following persons, whose signatures attest their acceptance of the
above restrictions.

NAME AND ADDRESS

DATE

YALE MEDICAL LIBRARY

9002 0 048 7339

